Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-14-020601)

Filing Details

Accession Number:: 0001209191-14-020601
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-03-14 15:27:19
Reporting Period:: 2014-03-12

Filing Date:: 2014-03-14
Accepted Time:: 2014-03-14 15:27:19
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1404644	Aquinox Pharmaceuticals Inc	AQXP	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
78003	Pfizer Inc	235 E. 42Nd Street New York NY 10017		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-03-12	962,603	$0.00	962,603	No	4	C	Direct
Common Stock	Acquisiton	2014-03-12	272,727	$11.00	1,235,330	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B-1 Preferred Stock	Disposition	2014-03-12	334,420	$0.00	334,420	$0.00
Common Stock	Series B-2 Preferred Stock	Disposition	2014-03-12	327,178	$0.00	327,178	$0.00
Common Stock	Series C Preferred Stock	Disposition	2014-03-12	301,005	$0.00	301,005	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct
0			No	4	C	Direct
0			No	4	C	Direct

Footnotes

Each share of the issuer's Series A-1, Series A-2, Series B-1, Series B-2 and Series C Preferred Stock converted into Common Stock of the issuer on a 1-to-1 basis upon the closing of the issuer's initial public offering, and has no expiration date.